Total Payments
$505.76
2023 Payments
$50.79
Companies
8
Transactions
27
Medicare Patients
2,261
Medicare Billing
$315,878
Payment Breakdown by Category
Food & Beverage$505.76 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $505.76 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $186.81 | 7 | $0 (2019) |
| PFIZER INC. | $109.60 | 8 | $0 (2018) |
| ABBVIE INC. | $82.80 | 3 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $71.70 | 5 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $16.56 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $13.80 | 1 | $0 (2019) |
| Novo Nordisk Inc | $12.57 | 1 | $0 (2017) |
| Inari Medical, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $50.79 | 1 | ABBVIE INC. ($50.79) |
| 2022 | $32.67 | 2 | Janssen Pharmaceuticals, Inc ($32.67) |
| 2021 | $70.29 | 5 | AbbVie Inc. ($32.01) |
| 2020 | $12.67 | 1 | Janssen Pharmaceuticals, Inc ($12.67) |
| 2019 | $156.82 | 5 | Allergan Inc. ($143.02) |
| 2018 | $79.40 | 6 | PFIZER INC. ($57.03) |
| 2017 | $103.12 | 7 | PFIZER INC. ($52.57) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $50.79 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/15/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/25/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/06/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/17/2021 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: VTE | ||||||
| 03/07/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/10/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $116.44 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/17/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/24/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/13/2018 | PFIZER INC. | ELELYSO (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: METABOLIC DISEASE | ||||||
| 11/20/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/28/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/27/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/24/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/28/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/21/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Diabetes | ||||||
| 11/09/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/26/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/20/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/21/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 529 | 770 | $584,867 | $73,029 |
| 2022 | 8 | 518 | 760 | $530,893 | $63,705 |
| 2021 | 9 | 615 | 919 | $719,608 | $87,642 |
| 2020 | 7 | 599 | 905 | $719,050 | $91,502 |
Total Patients
2,261
Total Services
3,354
Medicare Billing
$315,878
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 156 | 361 | $234,650 | $32,756 | 14.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 132 | 135 | $171,045 | $17,439 | 10.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 114 | 114 | $76,380 | $9,765 | 12.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 25 | 32 | $44,800 | $5,269 | 11.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 65 | 66 | $30,030 | $4,049 | 13.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 62 | $27,962 | $3,750 | 13.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 146 | 325 | $211,250 | $25,601 | 12.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 64 | 67 | $84,889 | $10,158 | 12.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 115 | 122 | $81,740 | $9,745 | 11.9% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 59 | 60 | $69,660 | $8,063 | 11.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 74 | $33,374 | $4,103 | 12.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 55 | 56 | $25,368 | $3,054 | 12.0% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 26 | 35 | $22,995 | $2,733 | 11.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Facility | 2022 | 13 | 21 | $1,617 | $248.13 | 15.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 160 | 400 | $260,000 | $32,111 | 12.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 94 | 100 | $126,700 | $15,102 | 11.9% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 102 | 108 | $125,388 | $14,723 | 11.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 137 | 143 | $95,810 | $11,714 | 12.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 22 | 42 | $58,800 | $7,356 | 12.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 49 | 50 | $22,650 | $2,803 | 12.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 27 | 42 | $18,942 | $2,366 | 12.5% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 13 | 15 | $9,855 | $1,234 | 12.5% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Facility | 2021 | 11 | 19 | $1,463 | $234.27 | 16.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 134 | 344 | $223,600 | $28,657 | 12.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 126 | 128 | $162,176 | $20,544 | 12.7% |
About Dr. Kenneth Parks, MD
Dr. Kenneth Parks, MD is a Emergency Medicine healthcare provider based in Mamou, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952349078.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Parks, MD has received a total of $505.76 in payments from pharmaceutical and medical device companies, with $50.79 received in 2023. These payments were reported across 27 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($505.76).
As a Medicare-enrolled provider, Parks has provided services to 2,261 Medicare beneficiaries, totaling 3,354 services with total Medicare billing of $315,878. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Internal Medicine
- Location Mamou, LA
- Active Since 06/02/2006
- Last Updated 05/27/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1952349078
Products in Payments
- VRAYLAR (Drug) $167.23
- XARELTO (Drug) $71.70
- AVYCAZ (Drug) $70.37
- CHANTIX (Drug) $62.62
- DALVANCE (Drug) $32.01
- ELIQUIS (Drug) $31.29
- ZERBAXA (Drug) $16.56
- ELELYSO (Drug) $15.69
- LOKELMA (Drug) $13.80
- Victoza (Drug) $12.57
- FLOWTRIEVER CATHETER, S (Device) $11.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.